Fig. 3.
Fig. 3. Identification of the novel mutation in RhCe gene by RT-PCR and sequencing. (A) Strategy for synthesis and amplification of Rh30 cDNA. Rh30 mRNA was reverse-transcribed into cDNA with either the gene-specific 3′-UTa primer or (dT)16 oligomer and then amplified with two pairs of upstream primers (Table 1). The cDNA products for Rh30 (left panel) and Rh50 (right panel) were separated on 1.8% agarose gels. Designations 1 through 6 are as in Fig 1. Lane a, 5′-UT/Ex-5a segment; lane b, Ex-4s/3′-UTa segment. Bands at bottom are primer dimers. (B) Nucleotide sequencing profiles for the novel double mutation identified in the amorph form of RhCe cDNAs from the 2 Rhnull patients (B.K. and D.R.). The mutation affects 2 codons (322 and 323) in exon 7, involving 2 single nucleotide deletions, ATT→AT (nt 965 or 966) and CAC→CC (nt 968) (indicated by arrow).

Identification of the novel mutation in RhCe gene by RT-PCR and sequencing. (A) Strategy for synthesis and amplification of Rh30 cDNA. Rh30 mRNA was reverse-transcribed into cDNA with either the gene-specific 3′-UTa primer or (dT)16 oligomer and then amplified with two pairs of upstream primers (Table 1). The cDNA products for Rh30 (left panel) and Rh50 (right panel) were separated on 1.8% agarose gels. Designations 1 through 6 are as in Fig 1. Lane a, 5′-UT/Ex-5a segment; lane b, Ex-4s/3′-UTa segment. Bands at bottom are primer dimers. (B) Nucleotide sequencing profiles for the novel double mutation identified in the amorph form of RhCe cDNAs from the 2 Rhnull patients (B.K. and D.R.). The mutation affects 2 codons (322 and 323) in exon 7, involving 2 single nucleotide deletions, ATT→AT (nt 965 or 966) and CAC→CC (nt 968) (indicated by arrow).

Close Modal

or Create an Account

Close Modal
Close Modal